CRISPR Therapeutics AG (CRSP)

Latest Insider Confidence Score

2026Q1

46.9
Bearish

Company insider confidence (by quarter)

2016Q4 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Vertex Pharmaceuticals (Europe) Ltd 10% Owner 5,380,940 Dec 28, 2018
Vertex Pharmaceuticals Inc / Ma 10% Owner 5,380,940 Dec 28, 2018
Bayer Aktiengesellschaft 10% Owner 5,105,330 Oct 18, 2016
Bayer Global Investments B.V. 10% Owner 5,105,330 Oct 18, 2016
Celgene Corp /de/ 10% Owner 3,722,534 Dec 7, 2017

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 18, 2026 Feb 20, 2026 Kulkarni Samarth CEO Sell 40.0 -6,967 -2.99% ✗ $366.3K
Feb 18, 2026 Feb 20, 2026 KASINGER JAMES R. General Counsel and Secretary Sell 42.5 -2,112 -2.42% ✗ $111K
Apr 3, 2025 Jan 27, 2026 Patel Naimish Chief Medical Officer Buy 91.3 +1,508 100.00% ✗ $49.7K
Jan 22, 2026 Jan 26, 2026 Prasad Raju CFO Sell 8.8 -34,972 -83.79% ✓ $2.1M
Jan 20, 2026 Jan 22, 2026 Kulkarni Samarth CEO Sell 8.1 -90,000 -29.05% ✓ $5.2M
Jan 6, 2026 Jan 8, 2026 Prasad Raju CFO Sell 8.8 -29,700 -81.44% ✓ $1.8M
Dec 22, 2025 Dec 23, 2025 Prasad Raju CFO Sell 10.0 -10,000 -59.64% ✓ $559.5K
Dec 18, 2025 Dec 22, 2025 Kulkarni Samarth CEO Neutral 27.5 -30,000 -8.83% ✗ -
Oct 16, 2025 Oct 20, 2025 Kulkarni Samarth CEO Sell 37.5 -50,895 -13.02% ✗ $3.5M
Oct 13, 2025 Oct 15, 2025 Kulkarni Samarth CEO Sell 40.0 -4,242 -1.44% ✗ $282.5K
Oct 13, 2025 Oct 15, 2025 KASINGER JAMES R. General Counsel and Secretary Sell 42.5 -1,076 -1.27% ✗ $71.7K
Oct 3, 2025 Oct 3, 2025 Kulkarni Samarth CEO Neutral 52.5 - 0.00% ✗ -
Oct 3, 2025 Oct 3, 2025 Patel Naimish Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Oct 3, 2025 Oct 3, 2025 KASINGER JAMES R. General Counsel and Secretary Neutral 52.5 - 0.00% ✗ -
Oct 3, 2025 Oct 3, 2025 Prasad Raju CFO Neutral 52.5 - 0.00% ✗ -
Sep 17, 2025 Sep 19, 2025 Kulkarni Samarth CEO Neutral 27.5 -6,000 -2.05% ✗ -
Aug 16, 2025 Aug 19, 2025 Kulkarni Samarth CEO Sell 40.0 -13,081 -4.28% ✗ $760.7K
Aug 6, 2025 Aug 8, 2025 Treco Douglas A Director Buy 100.0 +20,000 1000.00% ✗ $1.1M
Jul 16, 2025 Jul 17, 2025 George Simeon Director Buy 100.0 +989,812 94.36% ✗ $51.5M
Jun 10, 2025 Morrison Briggs Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2025 Jun 6, 2025 George Simeon Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2025 Jun 6, 2025 Behbahani Ali Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2025 Jun 6, 2025 Morrison Briggs Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2025 Jun 6, 2025 Treco Douglas A Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2025 Jun 6, 2025 Rommel Christian Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2025 Jun 6, 2025 Fleming Harold Edward Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2025 Jun 6, 2025 Greene John Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2025 Jun 6, 2025 Mahatme Sandesh Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2025 Jun 6, 2025 Fardis Maria Director Neutral 52.5 - 0.00% ✗ -
Jun 5, 2025 Jun 6, 2025 High Katherine A Director Neutral 52.5 - 0.00% ✗ -
Jun 6, 2025 Morrison Briggs Director Neutral 52.5 - 0.00% ✗ -
May 30, 2025 Jun 3, 2025 Prasad Raju CFO Neutral 52.5 - 0.00% ✗ -
May 30, 2025 Jun 3, 2025 Patel Naimish Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
May 28, 2025 May 30, 2025 Patel Naimish Chief Medical Officer Sell 42.5 -3,932 -39.32% ✗ $141.3K
Mar 20, 2025 Mar 24, 2025 Kulkarni Samarth CEO Sell 40.0 -10,031 -3.45% ✗ $413.6K
Mar 20, 2025 Mar 24, 2025 Bruno Julianne COO Sell 42.5 -1,714 -8.86% ✗ $70.7K
Mar 20, 2025 Mar 24, 2025 Prasad Raju CFO Sell 42.5 -2,197 -11.59% ✗ $90.6K
Mar 20, 2025 Mar 24, 2025 KASINGER JAMES R. General Counsel and Secretary Sell 42.5 -3,185 -3.75% ✗ $131.3K
Mar 14, 2025 Mar 18, 2025 Patel Naimish Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Mar 14, 2025 Mar 18, 2025 Kulkarni Samarth CEO Neutral 52.5 - 0.00% ✗ -
Mar 14, 2025 Mar 18, 2025 Prasad Raju CFO Sell 42.5 -3,762 -22.83% ✗ $157.3K
Mar 14, 2025 Mar 18, 2025 Bruno Julianne COO Neutral 52.5 - 0.00% ✗ -
Mar 14, 2025 Mar 18, 2025 KASINGER JAMES R. General Counsel and Secretary Neutral 52.5 - 0.00% ✗ -
Mar 10, 2025 Mar 12, 2025 Kulkarni Samarth CEO Sell 40.0 -14,435 -3.10% ✗ $616.3K
Mar 10, 2025 Mar 12, 2025 KASINGER JAMES R. General Counsel and Secretary Sell 42.5 -3,966 -2.48% ✗ $169.2K
Mar 10, 2025 Mar 12, 2025 Bruno Julianne COO Sell 42.5 -1,388 -5.50% ✗ $59.1K
Feb 26, 2025 Feb 28, 2025 Greene John Director Buy 97.5 +7,000 100.00% ✗ $313.9K
Feb 19, 2025 Feb 21, 2025 Kulkarni Samarth CEO Sell 27.5 -18,360 -6.66% ✓ $1M
Feb 18, 2025 Feb 19, 2025 Kulkarni Samarth CEO Sell 27.5 -18,568 -6.31% ✓ $1M
Feb 18, 2025 Feb 19, 2025 Bruno Julianne COO Sell 46.3 -333 -2.30% ✗ $17.6K
Feb 16, 2025 Feb 19, 2025 KASINGER JAMES R. General Counsel and Secretary Sell 40.0 -11,542 -7.24% ✗ $619.5K
Dec 24, 2024 Dec 27, 2024 Kulkarni Samarth CEO Neutral 52.5 - 0.00% ✗ -
Dec 2, 2024 Dec 4, 2024 Kulkarni Samarth CEO Sell 30.0 -15,000 -5.32% ✓ $826.6K
Nov 11, 2024 Nov 13, 2024 Kulkarni Samarth CEO Sell 23.8 -30,000 -9.61% ✓ $1.7M
Oct 16, 2024 Oct 18, 2024 KASINGER JAMES R. General Counsel and Secretary Neutral 52.5 - 0.00% ✗ -
Oct 16, 2024 Oct 18, 2024 Bruno Julianne COO Neutral 52.5 - 0.00% ✗ -
Oct 16, 2024 Oct 18, 2024 Kulkarni Samarth CEO Neutral 52.5 - 0.00% ✗ -
Oct 16, 2024 Oct 18, 2024 Patel Naimish Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Oct 16, 2024 Oct 18, 2024 Prasad Raju CFO Neutral 52.5 - 0.00% ✗ -
Oct 13, 2024 Oct 15, 2024 KASINGER JAMES R. General Counsel and Secretary Sell 42.5 -1,089 -1.71% ✗ $50.4K
Oct 13, 2024 Oct 15, 2024 Kulkarni Samarth CEO Sell 42.5 -4,293 -1.36% ✗ $198.7K
Aug 8, 2024 Aug 12, 2024 Kulkarni Samarth CEO Neutral 27.5 -100,000 -24.50% ✗ -
Jun 20, 2024 Jun 24, 2024 Bruno Julianne COO Sell 42.5 -3,366 -19.57% ✗ $188.8K
May 30, 2024 May 31, 2024 George Simeon Director Neutral 52.5 - 0.00% ✗ -
May 30, 2024 May 31, 2024 Behbahani Ali Director Neutral 52.5 - 0.00% ✗ -
May 30, 2024 May 31, 2024 Fardis Maria Director Neutral 52.5 - 0.00% ✗ -
May 30, 2024 May 31, 2024 Mahatme Sandesh Director Neutral 52.5 - 0.00% ✗ -
May 30, 2024 May 31, 2024 Rommel Christian Director Neutral 52.5 - 0.00% ✗ -
May 30, 2024 May 31, 2024 Greene John Director Neutral 52.5 - 0.00% ✗ -
May 30, 2024 May 31, 2024 High Katherine A Director Neutral 52.5 - 0.00% ✗ -
May 30, 2024 May 31, 2024 Treco Douglas A Director Neutral 52.5 - 0.00% ✗ -
May 30, 2024 May 31, 2024 Fleming Harold Edward Director Neutral 52.5 - 0.00% ✗ -
May 30, 2024 Mahatme Sandesh Director Neutral 52.5 - 0.00% ✗ -
May 30, 2024 Rommel Christian Director Neutral 52.5 - 0.00% ✗ -
May 28, 2024 May 29, 2024 Patel Naimish Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
May 28, 2024 Patel Naimish Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
May 23, 2024 May 24, 2024 Bruno Julianne COO Neutral 52.5 - 0.00% ✗ -
May 23, 2024 Bruno Julianne COO Neutral 52.5 - 0.00% ✗ -
Apr 15, 2024 Apr 17, 2024 Kulkarni Samarth CEO Sell 32.5 -19,582 -4.58% ✓ $1.2M
Mar 20, 2024 Mar 22, 2024 KASINGER JAMES R. General Counsel and Secretary Neutral 52.5 - 0.00% ✗ -
Mar 20, 2024 Mar 22, 2024 Prasad Raju CFO Neutral 52.5 - 0.00% ✗ -
Mar 20, 2024 Mar 22, 2024 Kulkarni Samarth CEO Neutral 52.5 - 0.00% ✗ -
Mar 14, 2024 Mar 18, 2024 Prasad Raju CFO Sell 40.0 -3,524 -35.24% ✗ $256.2K
Mar 15, 2024 Mar 18, 2024 Kulkarni Samarth CEO Sell 32.5 -20,000 -4.67% ✓ $1.4M
Mar 10, 2024 Mar 12, 2024 KASINGER JAMES R. General Counsel and Secretary Sell 40.0 -3,947 -3.15% ✗ $304.5K
Mar 10, 2024 Mar 12, 2024 Kulkarni Samarth CEO Sell 37.5 -14,385 -2.30% ✗ $1.1M
Feb 27, 2024 Feb 27, 2024 George Simeon Director Neutral 90.0 +1,048,951 100.00% ✗ -
Feb 18, 2024 Feb 21, 2024 KASINGER JAMES R. General Counsel and Secretary Sell 42.5 -1,913 -3.23% ✗ $152.4K
Feb 18, 2024 Feb 21, 2024 Kulkarni Samarth CEO Sell 40.0 -6,370 -1.59% ✗ $507.5K
Feb 15, 2024 Feb 16, 2024 Kulkarni Samarth CEO Sell 32.5 -20,000 -4.91% ✓ $1.6M
Jan 29, 2024 Jan 31, 2024 Kulkarni Samarth CEO Sell 20.0 -50,000 -11.43% ✓ $3M
Jan 16, 2024 Jan 18, 2024 Kulkarni Samarth CEO Sell 32.5 -20,000 -4.91% ✓ $1.3M
Oct 13, 2023 Oct 17, 2023 Prasad Raju CFO Neutral 52.5 - 0.00% ✗ -
Oct 13, 2023 Oct 17, 2023 Morrow Phuong Khanh Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Oct 13, 2023 Oct 17, 2023 Kulkarni Samarth CEO Neutral 52.5 - 0.00% ✗ -
Oct 13, 2023 Oct 17, 2023 KASINGER JAMES R. General Counsel and Secretary Neutral 52.5 - 0.00% ✗ -
Jun 8, 2023 Jun 9, 2023 George Simeon Director Neutral 52.5 - 0.00% ✗ -
Jun 8, 2023 Jun 9, 2023 Behbahani Ali Director Neutral 52.5 - 0.00% ✗ -
Jun 8, 2023 Jun 9, 2023 Treco Douglas A Director Neutral 52.5 - 0.00% ✗ -
Jun 8, 2023 Jun 9, 2023 High Katherine A Director Neutral 52.5 - 0.00% ✗ -